Félix Ratjen

1989–2025 年に発表

別表記
Felix Ratjen
166
論文数
24,755
被引用数
85
h 指数
160
i10 指数

被引用数

Félix Ratjen の年別被引用数1978 年: 被引用 1 件1993 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 6 件1999 年: 被引用 14 件2000 年: 被引用 26 件2001 年: 被引用 23 件2002 年: 被引用 28 件2003 年: 被引用 48 件2004 年: 被引用 75 件2005 年: 被引用 82 件2006 年: 被引用 72 件2007 年: 被引用 66 件2008 年: 被引用 74 件2009 年: 被引用 77 件2010 年: 被引用 78 件2011 年: 被引用 105 件2012 年: 被引用 115 件2013 年: 被引用 161 件2014 年: 被引用 153 件2015 年: 被引用 171 件2016 年: 被引用 192 件2017 年: 被引用 188 件2018 年: 被引用 193 件2019 年: 被引用 854 件2020 年: 被引用 945 件2021 年: 被引用 978 件2022 年: 被引用 717 件2023 年: 被引用 637 件2024 年: 被引用 971 件2025 年: 被引用 347 件2026 年: 被引用 3 件1979〜1992 年は被引用が無いため表示していません1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,814 件、この内訳の 24.3%イギリス: 引用元論文 776 件、この内訳の 10.4%カナダ: 引用元論文 530 件、この内訳の 7.1%ドイツ: 引用元論文 504 件、この内訳の 6.8%イタリア: 引用元論文 460 件、この内訳の 6.2%オーストラリア: 引用元論文 388 件、この内訳の 5.2%フランス: 引用元論文 387 件、この内訳の 5.2%オランダ: 引用元論文 302 件、この内訳の 4%中国: 引用元論文 193 件、この内訳の 2.6%スイス: 引用元論文 181 件、この内訳の 2.4%スペイン: 引用元論文 172 件、この内訳の 2.3%ベルギー: 引用元論文 159 件、この内訳の 2.1%
0%24.3%その他 21.4%

分野

  • Medicine77.4%
  • Biochemistry, Genetics and Molecular Biology12.7%
  • Immunology and Microbiology1.7%
  • Physics and Astronomy1.6%
  • Engineering1.4%
  • Environmental Science0.9%
  • その他4.3%

トピック

  • Cystic Fibrosis Research Advances19.6%
  • Neonatal Respiratory Health Research8.2%
  • Asthma and respiratory diseases4.4%
  • Tracheal and airway disorders4%
  • Bacterial biofilms and quorum sensing2.8%
  • Chronic Obstructive Pulmonary Disease (COPD) Research2.3%
  • その他58.7%

共著者

全論文

検索で開く
  1. The future of cystic fibrosis care: a global perspective

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ulrike Pypops, Karen S Raraigh, Steven M Rowe, Kevin W Southern, Sheila Sivam, Anne L Stephenson, Marco Zampoli, Felix Ratjen - The Lancet Respiratory Medicine 2019 被引用: 961

  2. Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2021 被引用: 380

  3. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 2,174

  4. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 1,621

  5. Cystic Fibrosis

    著者: , - New England Journal of Medicine 2023 被引用: 310

  6. ECFS best practice guidelines: the 2018 revision

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Cystic Fibrosis 2018 被引用: 764

  7. Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 140

  8. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anette Drøhse Kjeldsen, Masaki Komiyama, Kevin Korenblat, Jamie McDonald, Jack McMahon, Justin P. McWilliams, Mary E. Meek, Meir Mei‐Zahav, Scott E. Olitsky, Sara Palmer, Rose Pantalone, Jay F. Piccirillo, Beth Plahn, Mary Porteous, Marco C. Post, Ivan Radovanovic, Paul J. Rochon, Josanna Rodriguez‐Lopez, Carlo Sabbà, Marcelo M. Serra, Claire L. Shovlin, Dennis L. Sprecher, Andrew J. White, Ingrid Winship, Roberto Zarrabeitia - Annals of Internal Medicine 2020 被引用: 504

  9. Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele

    著者: , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 被引用: 129

  10. Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Cystic Fibrosis 2022 被引用: 123

  11. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jill M. VanDalfsen, Anna Mead, Rachael Buckingham, Kathy Seidel, Nikita Midamba, Laurel Couture, Brooke Zappone Case, Wendy Au, Elsie Rockers, Diane Cooke, Amber Olander, Irene Bondick, Miya Johnson, Lisya VanHousen, Boris Nicholson, Gregory J. Omlor, Michelle Parrish, Dion Roberts, Jillian Head, Jessica Carey, Lindsay J. Caverly, Joy Dangerfield, Rachel W. Linnemann, Jason Fullmer, Chelsea Roman, Peter J. Mogayzel, Deanne Reyes, Amy Harmala, Jerimiah Lysinger, Jonathan Bergeron, Isabel Virella‐Lowell, Perry Brown, Lejla Godusevic, Alicia Casey, Lauren Paquette, Thomas Lahiri, Julie Sweet, Scott H. Donaldson, Joshua D. Harris, Shelia Parnell, Sylvia Szentpetery, Deborah Froh, Erica Tharrington, Manu Jain, Rachel Nelson, Sharon Kadon, Gary L. McPhail, Kimberly McBennett, Tia Rone, Elliott C. Dasenbrook, D. J. Weaver, Terri Johnson, Karen McCoy, Raksha Jain, Maria Mcleod, Mary Klosterman, Preeti Sharma, Amy Jones, Gary A. Mueller, Rachel Janney, Jennifer L. Taylor‐Cousar, Mary Cross, Jordana E. Hoppe, James F. Cahill, Zubin Mukadam, Jill Finto, Karen D. Schultz, Silvia Delgado Villalta, Alexa Smith, Susan L. Millard ほか 106 名 - The Lancet Respiratory Medicine 2022 被引用: 126

  12. Cystic fibrosis

    著者: , , , , , - Nature Reviews Disease Primers 2015 被引用: 534

  13. Consensus statement for inert gas washout measurement using multiple- and single- breath tests

    著者: , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2013 被引用: 790

  14. Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Clinical Trial

    著者: , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 被引用: 65

  15. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gregory S. Sawicki, Michael J. Rock, Paul Aurora, Félix Ratjen, Anirban Maitra, Andrew Ives, Erol Gaillard, Paul McNalley, Hiranjan Selvadurai, Philip Robinson - The Lancet Respiratory Medicine 2018 被引用: 270

  16. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claire Wainwright, Natalie E. West, Michael Wilschanski, Amanda Bevan, Carlo Castellani, Pavel Dřevı́nek, Silvia Gärtner, Andrea Gramegna, Elise Lammertyn, E. Landau, Barry J. Plant, Alan R Smyth, Silke van Koningsbruggen‐Rietschel, Peter G. Middleton - Journal of Cystic Fibrosis 2024 被引用: 77

  17. PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Cystic Fibrosis 2021 被引用: 71

  18. Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Cystic Fibrosis 2023 被引用: 53

  19. Cystic Fibrosis Foundation Pulmonary Guideline. Pharmacologic Approaches to Prevention and Eradication of Initial Pseudomonas aeruginosa Infection

    著者: , , , , , , , , , , , , , , - Annals of the American Thoracic Society 2014 被引用: 266

  20. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein

    著者: , , , , , , , , - Nature Biotechnology 2012 被引用: 433

  21. Modes of Infant Feeding and the Risk of Childhood Asthma: A Prospective Birth Cohort Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hartmut Grasemann, Sharon Dell, Teresa To, Theo J. Moraes, Padmaja Subbarao, Linn D. Holness, A. Dean Befus, Piush J. Mandhane, Catherine Laprise, James A. Scott, Richard G. Hegele, Wendy Lou, Sonia S. Anand, Malcolm R. Sears, Elinor Simons, Meghan B. Azad, Thomas Eiwegger, Qing Duan, Perry Hystad, Jeremy A. Scott, Perry Hystad, Jeremy A. Scott - The Journal of Pediatrics 2017 被引用: 150

  22. The Effect of Chronic Infection With Aspergillus fumigatus on Lung Function and Hospitalization in Patients With Cystic Fibrosis

    著者: , , , - CHEST Journal 2009 被引用: 371

  23. Normative multiple-breath washout data in school-aged children corrected for sensor error

    著者: , , , , , , , , , , , , , - European Respiratory Journal 2022 被引用: 44

  24. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines

    著者: , , , , , , , , , , , , , , - Journal of Cystic Fibrosis 2014 被引用: 592